Tolerability and clinical safety of Implanon.

  title={Tolerability and clinical safety of Implanon.},
  author={Paul D. Blumenthal and Kristina Gemzell-Danielsson and Maya Marintcheva-Petrova},
  journal={The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception},
  volume={13 Suppl 1},
OBJECTIVES To evaluate the tolerability and clinical safety of the subdermal, long-acting hormonal contraceptive Implanon. METHODS This integrated safety analysis included 11 international studies concerning Implanon (68 mg etonogestrel) of which 10 had a duration of at least two years. Assessments included reports of adverse events (AEs), reasons and rates of discontinuation, insertion/removal complications, and the condition of the implant site. Metabolic and coagulation parameters are… CONTINUE READING